Simon Cradick

Gary Born is the chair of the International Arbitration Practice Group. Mr. Born is widely regarded as the world's preeminent authority on international commercial arbitration and international litigation. He has been ranked for more than 20 years as one of the world's leading international arbitration advocates and the leading arbitration practitioner in London.

Arvin Abraham is a top attorney recognized by Best Lawyers in the practice area(s) of FinTech. Arvin, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Arvin is held by other top lawyers in the same geographic and legal practice area.

Graham Defries is a top attorney recognized by Best Lawyers in the practice area(s) of Life Sciences Law. Graham, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Graham is held by other top lawyers in the same geographic and legal practice area.

Michael Kazakevich is a partner in Ropes & Gray’s finance group in London, co-head of the firm’s global practice, and co-chair of the firm’s investment banking industry group. Michael’s practice focuses on corporate finance transactions. He has advised issuers and underwriters in connection with high yield debt issues, secured leveraged loans, initial and follow-on public equity offerings, tender offers and acquisition financing commitments.

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...

Wim De Vlieger is a partner in the London office of Gibson, Dunn & Crutcher. Mr. De Vlieger is Co-Head of Private Equity in Europe and a member of the Mergers and Acquisitions and Capital Markets practice groups. Mr. De Vlieger advises private equity investors and their portfolio companies on a wide range of corporate transactions, including growth equity and control investments and co-investments, structured transactions, buy-out transactions, mergers and acquisitions, and exits. He also...

Brenda Coleman specialises in all aspects of corporate tax including private equity, fund formation, public and private M&A, restructurings, complex financings and tax disputes. Her experience includes acting for private equity funds, multi-asset managers, LPs, multinational companies, banks, hedge funds, Sovereign wealth funds and various UK Government departments. Brenda is described in Chambers UK 2022 as “extremely capable, very analytical and very thorough.” Clients say &...

Mark Sperotto is a partner in the London office of Gibson, Dunn and Crutcher and a member of the Corporate Transactional practice group. Mr. Sperotto has broad experience in both the UK and Italian markets, covering all aspects of corporate, private equity and investment banking with a focus on cross-border M&A, leveraged buy-outs, fund establishment and international corporate finance and equity capital markets transactions. Mr. Sperotto’s experience extends to advising private equ...

Bill Schnoor is a partner in and former co-chair of the firm’s Technology and Life Sciences groups. He works in all areas of corporate, securities and partnership laws, with a primary focus on advising high-growth technology and life sciences companies. He joined Goodwin in 2005, after a 21-year career with Testa, Hurwitz & Thibeault, LLP, and quickly became co-chair of Goodwin’s technology and life sciences practices. Under his leadership the Technology and Life Sciences grou...

Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector. Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies. Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devi...